Scientists seek people with Down syndrome to test Alzheimer’s drugs

Many people with Down syndrome develop Alzheimer’s as they age due to amyloids that cause brain inflammation. Scientists are working with people with Down's Syndrome to help understand drugs to improve cognition.

People younger than age 65 can develop Alzheimer's disease—and symptoms are often overlooked.

The FDA approved the drug lecanemab in 2023. Learn where treatment stands for this progressive disease.

You can’t change your genes or roll back aging, but taking these steps may help reduce your risk of cognitive decline.

Read these tips from leading Alzheimer's caregivers, activists, and educators.

While much of your cancer risk is out of your hands, you may be able to lower your odds by managing your weight.